机器人辅助全髋关节置换前路与后路入路的重建精准度与临床效果比较
本研究为前瞻性随机对照试验,纳入98例单侧股骨头缺血性坏死或原发性髋关节骨性关节炎患者,比较机器人辅助传统后路(RA-PLA)与直接前路(RA-DAA)全髋关节置换术。剔除学习曲线拐点前病例后每组各30例,结果显示两组术后2年临床效果相似,髋臼杯植入角度、下肢长度差、髋关节偏心距和旋转中心高度重建精度无显著差异,但RA-DAA组假体规划完全准确率更高。
要点
- RA-DAA与RA-PLA术后2年临床效果相似,患者报告结局指标组间无差异。
- 两组髋臼杯植入角度、下肢长度差、偏心距和旋转中心高度重建精度无显著差异。
- RA-DAA组假体规划完全准确率高于RA-PLA组(86.7% vs 63.3%,P=0.037)。
核心结论
- RA-DAA和RA-PLA全髋关节置换术后2年临床效果相似,均可获得满意的重建精度。
- RA-DAA术中假体规划准确率高于RA-PLA。
研究设计与样本
- 前瞻性随机对照研究,纳入2022年5—9月陆军军医大学新桥医院骨科收治的单侧股骨头缺血性坏死或原发性髋关节骨性关节炎患者。
- 通过中央随机法分为RA-PLA组和RA-DAA组,共98例(RA-PLA组48例,RA-DAA组50例)。
- 剔除学习曲线拐点前病例后,两组各纳入30例进行分析。
主要发现
- 两组髋臼杯前倾角和外展角与术前规划均无显著差异(P值均>0.05)。
- RA-PLA组和RA-DAA组术后髋臼假体方位角落入安全区的比例分别为90.0%(27/30)和96.7%(29/30)(χ2=0.268,P=0.605)。
- 两组术后双下肢长度差、髋关节偏心距和旋转中心高度差无显著差异(P值均>0.05)。
- RA-DAA组假体规划完全准确率高于RA-PLA组[86.7%(26/30)比63.3%(19/30),χ2=4.356,P=0.037]。
- 两组术后HHS、WOMAC及SF-12评分均较术前明显改善(P值均<0.05),但组间差异无统计学意义(P值均>0.05);围手术期并发症和不良事件发生率无差异[20.0%(6/30)比13.3%(4/30),χ2=0.480,P=0.488]。
关键数值与推荐
- 假体规划完全准确率定义为术中实际使用髋臼杯假体、股骨柄假体规格、颈干角与手术规划完全一致的例数/总例数×100%。
- RA-DAA组假体规划完全准确率为86.7%(26/30),RA-PLA组为63.3%(19/30),组间比较χ2=4.356,P=0.037。
临床怎么用
- 对于接受机器人辅助全髋关节置换术的患者,RA-DAA与RA-PLA均可作为可选入路,两者术后2年临床效果和重建精度相似。
- 若追求更高的假体规划准确率,可优先考虑RA-DAA入路。
局限性
- 本研究仅纳入单中心患者,样本量有限(剔除后每组30例)。
- 随访时间为2年,缺乏更长期临床结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the differences in prosthesis implantation accuracy, biomechanical indicators, and 2-year postoperative clinical outcomes between robotic-assisted traditional posterior approach (RA-PLA) and robotic-assisted direct anterior approach (RA-DAA) in total hip arthroplasty (THA). Methods: This study is a prospective randomized controlled trial. Patients with unilateral femoral head ischemic necrosis or primary hip osteoarthritis who meet the inclusion and exclusion criteria and were admitted to the Department of Orthopedics,Xinqiao Hospital, Army Medical University from May to September 2022. Divided into RA-PLA group and RA-DAA group through central randomization. Use cumulative and fitting methods to analyze the learning curve of robotic surgery and eliminate cases before the inflection point of the learning curve. Compare the abduction angle and anteversion angle of acetabular cup implantation between two groups of patients, as well as the rate of falling into the safe zone, the difference in length between the two lower limbs, hip joint eccentricity, rotation center height, the complete accuracy of prosthesis planning (the number of cases in which acetabular cup prosthesis, femoral stem prosthesis specifications, and neck shaft angle were completely consistent with surgical planning during surgery/total cases×100%), patient reported outcome indicators (including Harris hip score (HHS), Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC), and 12 item Short Form Health Survey (SF-12) score) and clinical outcomes. Data comparison was conducted using independent sample t-test, Wilcoxon rank sum test, chi square test, Fisher's exact probability method, or repeated measures analysis of variance. Results: A total of 98 patients were included in this study, with 48 in the RA-PLA group and 50 in the RA-DAA group. After excluding cases before the inflection point of the learning curve, 30 patients were included in each group. There was no statistically significant difference in baseline data between the two groups before surgery (all P>0.05). There was no significant difference in the values of the anterior tilt angle and abduction angle between the two groups of acetabular cups compared to preoperative planning (all P>0.05). The proportion of patients who fell into the Lewinnek and Callanan safe zones was 90.0% (27/30) and 96.7% (29/30), respectively (χ2=0.268, P=0.605). There was no significant difference in postoperative lower limb length, hip joint eccentricity, and rotation center height deviation and grading between the two groups (all P>0.05). The complete accuracy of prosthesis planning in the RA-DAA group was higher than that in the RA-PLA group (86.7% (26/30) compared to 63.3% (19/30),χ2=4.356,P=0.037).All patients were followed up for more than 2 years. In terms of postoperative HHS, WOMAC, and SF-12 score, there was no statistically significant difference in the inter group effect comparison (all P>0.05), but there was a significant statistical significance in the time effect (all P<0.05). There was no significant difference in the incidence of perioperative complications and adverse events between the RA-DAA group and the RA-PLA group (20.0% (6/30) vs. 13.3% (4/30),χ2=0.480,P=0.488). Conclusions: RA-DAA and RA-PLA techniques can achieve similar clinical efficacy after two years of surgery, and both can achieve similar reconstruction accuracy in terms of acetabular cup implantation angle, lower limb length, hip joint eccentricity, and rotation center height. The accuracy of prosthesis planning in RA-DAA is higher. 目的: 比较机器人辅助传统后路(RA-PLA)和直接前路(RA-DAA)全髋关节置换术的手术精准度与临床效果。 方法: 本研究为前瞻性随机对照研究。纳入2022年5—9月陆军军医大学新桥医院骨科收治的符合纳入和排除标准的单侧股骨头缺血性坏死或原发性髋关节骨性关节炎患者的病历资料。通过中央随机法将患者分为RA-PLA组和RA-DAA组。使用累计和拟合法分析机器人辅助手术的学习曲线,并剔除学习曲线拐点前的病例。测量两组患者髋臼杯植入的外展角和前倾角,并计算其落入Lewinnek和Callanan安全区的比例,比较两组双下肢长度差、髋关节偏心距、旋转中心高度、假体规划完全准确率(术中实际使用髋臼杯假体、股骨柄假体规格、颈干角与手术规划完全一致性的例数/总例数×100%)、患者报告结局指标[包括Harris髋关节评分(HHS)、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)、健康评估12项简表(SF-12)评分]、临床结局等的差异。数据比较采用独立样本t检验、Wilcoxon秩和检验、χ2检验、Fisher确切概率法或重复测量方差分析。 结果: 共98例患者纳入本研究,RA-PLA组48例,RA-DAA组50例,剔除学习曲线拐点前病例后,两组分别纳入30例。两组术前基线资料的差异均无统计学意义(P值均>0.05)。两组髋臼杯前倾角和外展角数值与术前规划均无差异(P值均>0.05),RA-PLA组和RA-DAA组术后髋臼假体方位角落入安全区的比例分别为90.0%(27/30)和96.7%(29/30)(χ2=0.268,P=0.605)。两组术后双下肢长度差、髋关节偏心距和旋转中心高度差无差异(P值均>0.05)。RA-DAA组假体规划完全准确率高于RA-PLA组[86.7%(26/30)比63.3%(19/30),χ2=4.356,P=0.037]。患者均获得2年以上随访,两组术后及末次随访时的HHS评分、WOMAC及SF-12评分均较术前明显改善(P值均<0.05),但组间差异无统计学意义(P值均>0.05)。RA-DAA和RA-PLA组围手术期并发症和不良事件发生率无差异[20.0%(6/30)比13.3%(4/30),χ2=0.480,P=0.488]。 结论: 接受RA-DAA和RA-PLA全髋关节置换术患者术后2年临床效果相似,均可获得满意的髋臼杯植入角度值、下肢长度、髋关节偏心距和旋转中心高度的重建精度,但RA-DAA术中假体规划准确率更高。.
引用
- Cheng ZM, Xu ZH, Man XJ, et al. [A comparative study evaluating reconstructive accuracy and clinical result of robotic total hip arthroplasty via anterior and posterior approaches]. Zhonghua Wai Ke Za Zhi. 2025. PMID: 41015482. doi:10.3760/cma.j.cn112139-20250228-00102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。